| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 02/28/2002 | WO2002016381A2 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | WO2002015913A1 Treatment of trauma, and other indications |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/28/2002 | DE10040103A1 Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II Peptide and peptide derivatives with integrin inhibitor properties II |
| 02/28/2002 | CA2425206A1 Treatment of trauma, and other indications |
| 02/28/2002 | CA2420179A1 Composition and method for inhibiting platelet aggregation |
| 02/27/2002 | EP1181035A2 Substantially oil-free cyclosporin compositions |
| 02/27/2002 | EP1181026A2 Improved method for treating mammals with modified mammalian blood |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 02/27/2002 | CN1079642C Novel embolizing compositions |
| 02/26/2002 | US6350745 Thrombin inhibitors |
| 02/21/2002 | WO2002014350A2 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
| 02/21/2002 | WO2001085256A3 Critical illness neuropathy |
| 02/21/2002 | WO2001079443A3 Albumin fusion proteins |
| 02/21/2002 | WO2001045717A3 Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors |
| 02/21/2002 | US20020020462 Process and plant for the dynamic packaging of gases, especially those for medical use |
| 02/21/2002 | DE10039998A1 Neue substituierte Diareno-azepin-Derivate als Integrin Liganden New substituted Diareno-azepine derivatives as integrin ligands |
| 02/21/2002 | CA2419469A1 Derivatives of peptides and peptide mimetics having integrin inhibitor properties ii |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/14/2002 | WO2001059068A3 Artificial bone chips, methods for the production thereof and their use |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | US20020019424 1-sulfonyl pyrrolidine derivatives |
| 02/13/2002 | EP1178809A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
| 02/07/2002 | WO2002010348A2 Tissue implant for cartilage repair |
| 02/07/2002 | CA2417688A1 Tissue implant for cartilage repair |
| 02/06/2002 | EP1177287A2 Secreted human proteins |
| 02/06/2002 | EP1177200A1 Ligands for metabotropic glutamate receptors |
| 02/06/2002 | EP1176980A1 Ccr4 antagonists in sepsis |
| 02/06/2002 | EP1162990A4 Treatment with small peptides to effect antifibrotic activity |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | US20020013341 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, Bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 01/31/2002 | US20020013331 For therapy of pain associated with mucosal damage, such as inflamation, abrasions, ulcerations, lesions, incisions, and trauma |
| 01/31/2002 | US20020012678 Applying a mixture comprising polymerizable 1,1-disubstituted ethylene adhesive monomer and polydimethylsiloxane, a siloxane monomer or polymer, a fluorinated siloxane, and a siloxane on an area of tissue where scar tissue is present |
| 01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
| 01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
| 01/29/2002 | CA2207624C Selective and non-invasive visualization or treatment of vasculature |
| 01/24/2002 | WO2002005848A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/24/2002 | US20020010146 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 01/24/2002 | DE10033283A1 Verwendung eines flüssigen Medikamentes zur Behandlung von Dissektionsebenen Resektionsflächen an einer biologischen Struktur und zur gleichzeitigen Trennung der biologischen Struktur und Hochdruckflüssigkeitsstrahleinrichtung zur Durchführung des Verfahrens Use of a liquid medicament for the treatment of Dissektionsebenen resection surfaces on a biological structure, and for the simultaneous separation of the biological structure and high pressure liquid jet means for performing the method |
| 01/24/2002 | CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/23/2002 | EP1174178A1 Process and plant for dynamic gas conditioning, in particular for medical use |
| 01/23/2002 | EP1173567A2 Tribonectins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173255A2 Use of pirenoxine for the protection of corneal tissues in photokeratectomy |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/17/2002 | WO2002004002A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 01/17/2002 | WO2002003871A1 Use of a liquid medicament in surgical high pressure liquid jet devices |
| 01/17/2002 | US20020006923 Thrombin inhibitors |
| 01/17/2002 | CA2415124A1 Use of a liquid medicament in surgical high pressure liquid jet devices |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171155A2 Therapeutic compositions and methods for enhancing angiogenesis |
| 01/16/2002 | EP1171136A2 Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions |
| 01/15/2002 | US6339072 Compositions and methods for preventing restenosis following revascularization procedures |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002554A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | CA2413243A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/09/2002 | EP1169069A1 Three-dimensional stromal tissue |
| 01/09/2002 | EP1169045A2 Immunomodulating polymers |
| 01/09/2002 | CN1330638A Substituted benzo (de) isoquinoline-1,3-diones |
| 01/09/2002 | CN1330555A Antibodies to truncated VEGF-D and uses thereof |
| 01/03/2002 | WO2002000195A2 Methods and compositions for treating pain of the mucous membrane |
| 01/03/2002 | WO2001055336A3 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/03/2002 | CA2413545A1 Methods and compositions for treating pain of the mucous membrane |
| 01/02/2002 | EP1165781A2 Protease resistant flint analogs |
| 12/27/2001 | WO2001098473A2 Method for isolating and purifying a protein and resulting protein |
| 12/27/2001 | WO2001098286A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | WO2001085719A9 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 12/27/2001 | WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/26/2001 | CN1328469A Use of parvovirus capsid particles in inhibition of cell proliferation and migration |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096300A1 Growth hormone secretagogues |
| 12/20/2001 | WO2001095932A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 12/20/2001 | WO2001095919A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 12/20/2001 | WO2001066550A3 Compounds for pdt |
| 12/20/2001 | CA2410610A1 Human kinases |
| 12/20/2001 | CA2410228A1 A combination product comprising melagatran and a factor viia inhibitor |
| 12/19/2001 | EP1162990A1 Treatment with small peptides to effect antifibrotic activity |
| 12/19/2001 | EP1162984A2 Use of cross linked polysaccharides for the inhibition of angiogenesis |
| 12/19/2001 | EP1085920B1 Dextrin-containing composition for preventing surgical adhesions |
| 12/19/2001 | EP0717634B1 Injectable compositions for soft tissue augmentation |
| 12/18/2001 | US6331546 Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions |
| 12/13/2001 | WO2001094347A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | DE10025609A1 Transfektionssystem Transfection |
| 12/13/2001 | CA2411010A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
| 12/12/2001 | EP1161245A1 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
| 12/12/2001 | EP0730465B1 Use of angiotensin iii and analogs thereof in tissue repair |
| 12/06/2001 | WO2001092262A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 12/06/2001 | WO2001091775A2 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | US20010049348 Interaction of NMDA receptor with protein tyrosine phosphatase |
| 12/06/2001 | CA2409359A1 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |